181 related articles for article (PubMed ID: 35733089)
1. Detection of antiviral drug resistance in patients with congenital cytomegalovirus infection using long-read sequencing: a retrospective observational study.
Torii Y; Horiba K; Kawada JI; Haruta K; Yamaguchi M; Suzuki T; Uryu H; Kashiwa N; Goishi K; Ogi T; Ito Y
BMC Infect Dis; 2022 Jun; 22(1):568. PubMed ID: 35733089
[TBL] [Abstract][Full Text] [Related]
2. Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymporphism with impact on phenotypic drug-resistance.
Fischer L; Imrich E; Sampaio KL; Hofmann J; Jahn G; Hamprecht K; Göhring K
Antiviral Res; 2016 Jul; 131():1-8. PubMed ID: 27058773
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation.
Göhring K; Wolf D; Bethge W; Mikeler E; Faul C; Vogel W; Vöhringer MC; Jahn G; Hamprecht K
J Clin Virol; 2013 May; 57(1):43-9. PubMed ID: 23375740
[TBL] [Abstract][Full Text] [Related]
4. Antiviral treatment in congenital HCMV infection: The six-year experience of a single neonatal center in Poland.
Jedlińska-Pijanowska D; Czech-Kowalska J; Kłodzińska M; Pietrzyk A; Michalska E; Gradowska K; Dobrzańska A; Kasztelewicz B; Gruszfeld D
Adv Clin Exp Med; 2020 Oct; 29(10):1161-1167. PubMed ID: 33053275
[TBL] [Abstract][Full Text] [Related]
5. Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study.
Campos AB; Ribeiro J; Pinho Vaz C; Campilho F; Branca R; Campos A; Baldaque I; Medeiros R; Boutolleau D; Sousa H
Antiviral Res; 2017 Feb; 138():86-92. PubMed ID: 27887982
[TBL] [Abstract][Full Text] [Related]
6. Onset of valganciclovir resistance in two infants with congenital cytomegalovirus infection.
Garofoli F; Lombardi G; Angelini M; Campanini G; Zavattoni M; Baldanti F
Int J Infect Dis; 2020 Sep; 98():150-152. PubMed ID: 32615325
[TBL] [Abstract][Full Text] [Related]
7. Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan.
Yang SL; Lin TW; Lin HC; Wang HY; Chang PY; Wang PN; Yang S; Lu JJ
J Microbiol Immunol Infect; 2021 Oct; 54(5):971-978. PubMed ID: 33632621
[TBL] [Abstract][Full Text] [Related]
8. Genotypic analysis of cytomegalovirus retinitis poorly responsive to intravenous ganciclovir but responsive to the ganciclovir implant.
Kuo IC; Imai Y; Shum C; Martin DF; Kuppermann BD; Margolis TP
Am J Ophthalmol; 2003 Jan; 135(1):20-5. PubMed ID: 12504692
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of cytomegalovirus populations harbouring mutations in genes UL54 and UL97 in a haematopoietic stem cell transplant recipient.
Schnepf N; Dhédin N; Mercier-Delarue S; Andreoli A; Mamez AC; Ferry C; Deback C; Ribaud P; Robin M; Socié G; Simon F; Mazeron MC
J Clin Virol; 2013 Dec; 58(4):733-6. PubMed ID: 24183928
[TBL] [Abstract][Full Text] [Related]
10. [Mutations in the
Demin MV; Tikhomirov DS; Biderman BV; Drokov MY; Sudarikov AB; Tupoleva TA; Filatov FP
Vopr Virusol; 2022 Mar; 67(1):37-47. PubMed ID: 35293187
[TBL] [Abstract][Full Text] [Related]
11. Emergence of antiviral resistance during oral valganciclovir treatment of an infant with congenital cytomegalovirus (CMV) infection.
Choi KY; Sharon B; Balfour HH; Belani K; Pozos TC; Schleiss MR
J Clin Virol; 2013 Aug; 57(4):356-60. PubMed ID: 23688863
[TBL] [Abstract][Full Text] [Related]
12. Rapid detection by reverse hybridization of mutations in the UL97 gene of human cytomegalovirus conferring resistance to ganciclovir.
Zhou L; Harder TC; Ullmann U; Rautenberg P
J Clin Virol; 1999 Jun; 13(1-2):53-9. PubMed ID: 10405892
[TBL] [Abstract][Full Text] [Related]
13. Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis.
Boivin G; Goyette N; Gilbert C; Covington E
J Med Virol; 2005 Nov; 77(3):425-9. PubMed ID: 16173018
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance.
Recio V; González I; Tarragó D
Virol J; 2023 Jul; 20(1):153. PubMed ID: 37464399
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
[TBL] [Abstract][Full Text] [Related]
18. Analysis of HHV-6 mutations in solid organ transplant recipients at the onset of cytomegalovirus disease and following treatment with intravenous ganciclovir or oral valganciclovir.
Bounaadja L; Piret J; Goyette N; Boivin G
J Clin Virol; 2013 Sep; 58(1):279-82. PubMed ID: 23871165
[TBL] [Abstract][Full Text] [Related]
19. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
Myhre HA; Haug Dorenberg D; Kristiansen KI; Rollag H; Leivestad T; Asberg A; Hartmann A
Transplantation; 2011 Jul; 92(2):217-23. PubMed ID: 21685829
[TBL] [Abstract][Full Text] [Related]
20. Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay.
Fischer L; Sampaio KL; Jahn G; Hamprecht K; Göhring K
J Clin Virol; 2015 Aug; 69():150-5. PubMed ID: 26209398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
